NIH-funded research Fellowship grant

How the body's internal clock affects sexual drive and reproduction

Official title: Hypothalamic circuitry underlying the circadian control of sexual drive and reproduction

Funded at Beth Israel Deaconess Medical Center · NIH-10825135 · Data updated 2026-11-12

This study looks at how our body's internal clock affects our sexual behavior and ability to have children, helping people understand how their daily rhythms might influence their reproductive health.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$81,256
NIH project number1F32HD111339-01A1
Project IDNIH-10825135 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals experiencing difficulties with fertility or sexual drive, particularly those affected by circadian rhythm disruptions.

Less likely to help

Patients who do not have issues related to fertility or sexual behavior may not benefit from this research.

What this research studies

This research investigates how the circadian clock influences sexual behavior and reproductive success in humans and other mammals. It focuses on the role of specific neural circuits and hormones regulated by the body's master clock, the suprachiasmatic nucleus (SCN). By examining the effects of disrupted biological rhythms on fertility, the study aims to uncover the relationship between timing, sexual drive, and reproductive outcomes. Patients may learn how their own circadian rhythms could impact their reproductive health.

Why it matters

Potential benefit: If successful, this research could lead to new insights and strategies for improving fertility and sexual health.

How similar studies have gone: Previous research has shown that disruptions in circadian rhythms can negatively impact fertility, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Aten, Sydney Elizabeth — Beth Israel Deaconess Medical Center
  • Study coordinator: Aten, Sydney Elizabeth

Related research

Other NIH-funded projects on the same topics.

  • SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers

    This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625633

  • Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study

    This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625632

  • Statin use after brain bleed: SATURN MRI ancillary study

    This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625628

  • XenCAT: Single Cell Atlas for Xenopus

    Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11594482

  • Statin use after lobar intracerebral hemorrhage

    This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518526

  • Statin use after lobar brain hemorrhage

    This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518525

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.